Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey

• DOI: 10.1007/s00228-012-1221-x
• Publication Date: 2012-02-03T02:59:25Z
• Authors: Goran Palčevski; Nataša Skočibušić; Vera Vlahović-Pal...
• Keywords: Off-label use; Cross-sectional study; Marketing authorization; Mandate

The aim of this study was to determine the prevalence and pattern of unlicensed and off-label drugs prescribed to hospitalized children at the Department of Paediatrics, University Hospital Rijeka, Croatia.A prospective cross-sectional study was performed on 1 day each month during a 12 month period and included all hospitalized children and adolescents.A total of 1,643 prescriptions for 198 different drugs were prescribed to 531 out of 691 (77%) hospitalized patients. Forty-six percent of the different drugs were prescribed in an unlicensed or off-label manner. Of all drug prescriptions, 25% were either unlicensed or off-label. Forty-eight percent of the patients received either an unlicensed or off-label drug. The most frequently prescribed off-label drugs were proton pump inhibitors.Unlicensed and off-label drug use is common. It is not illegal and may be clinically appropriate but is associated with a number of clinical, safety, and ethical issues. Regulatory authorities should use existing clinical evidence on the use of off-label and unlicensed drugs in decision making. Marketing authorization holders and national regulatory authorities should monitor for any safety concerns associated with unlicensed and off-label drug use and take appropriate measures as well as identify research priorities and mandate clinical studies to resolve important questions.